Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
The latest announcement is out from Cannabix Technologies ( (TSE:BLO) ).
Cannabix Technologies announced its participation in a workshop hosted by the U.S. National Institute of Standards and Technology (NIST) focused on cannabis breathalyzer technology. This event will gather key stakeholders from various sectors to discuss advancements in cannabis breathalyzer realization. Cannabix will present its Marijuana Breath Test (MBT) technology, which utilizes proprietary technologies to detect recent cannabis use. This participation underscores Cannabix’s commitment to advancing breath testing technology and could enhance its positioning in the industry by aligning with federal standards and engaging with influential stakeholders.
Spark’s Take on TSE:BLO Stock
According to Spark, TipRanks’ AI Analyst, TSE:BLO is a Underperform.
Cannabix Technologies has a low overall stock score due to severe financial challenges, characterized by zero revenue and ongoing losses. While technical indicators and recent corporate developments provide some optimism, the company’s speculative valuation and financial instability remain significant concerns.
To see Spark’s full report on TSE:BLO stock, click here.
More about Cannabix Technologies
Cannabix Technologies Inc. is a company specializing in the development of marijuana and alcohol breath testing devices. Their products are aimed at enhancing safety and monitoring in workplaces, law enforcement, and other settings by focusing on detecting recent marijuana use through breath testing for delta-9 THC, the primary psychoactive ingredient in cannabis.
Average Trading Volume: 27,770
Technical Sentiment Signal: Hold
Current Market Cap: C$66.59M
For an in-depth examination of BLO stock, go to TipRanks’ Overview page.